Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0353 Transporter Info | ||||
Gene Name | SLC40A1 | ||||
Transporter Name | Iron-regulated transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
BACH1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC40A1 gene in ferroptosis condition | [1] | ||||
TF Protein Name |
Transcription regulator protein BACH1 | Transcription Factor Info | ||||
Studied Phenotype |
Ferroptosis [ICD11: N.A.] | |||||
Tissue |
Embryo | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
C57BL/6J Bach1KO mice | |||||
Detailed Description |
Transcription regulator protein BACH1 (BACH1) has been reported to repress the transcription of SLC40A1 gene in ferroptosis condition, which leads to a decreased expression of the drug transporter Iron-regulated transporter 1. | |||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC40A1 gene | [2] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC40A1 gene, which in turn affects the expression or function of the drug transporter Iron-regulated transporter 1. | |||||
CEBPD |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC40A1 gene | [3] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein delta | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein delta (CEBPD) can directly bind to the SLC40A1 gene, which in turn affects the expression or function of the drug transporter Iron-regulated transporter 1. | |||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC40A1 gene | [4] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC40A1 gene, which in turn affects the expression or function of the drug transporter Iron-regulated transporter 1. | |||||
NFE2L2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC40A1 gene in ovarian endometrioid adenocarcinoma condition | [5] | ||||
TF Protein Name |
Nuclear factor erythroid 2-related factor 2 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Cisplatin | |||||
Studied Phenotype |
Ovarian endometrioid adenocarcinoma [ICD11: 2C73.01] | |||||
Tissue |
Ovary | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human ovarian endometrioid adenocarcinoma cells (A2780) | |||||
Detailed Description |
Nuclear factor erythroid 2-related factor 2 (NFE2L2) has been reported to repress the transcription of SLC40A1 gene in ovarian endometrioid adenocarcinoma condition, which leads to a decreased expression of the drug transporter Iron-regulated transporter 1. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
EPAS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC40A1 gene in health condition | [6] | ||||
TF Protein Name |
Endothelial PAS domain-containing protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Endothelial PAS domain-containing protein 1 (EPAS1), influenced by the generated by Lactobacillus reuteri, has been reported to activate the transcription of SLC40A1 gene in health condition, which leads to an increased expression of the drug transporter Iron-regulated transporter 1. | |||||
TCF4 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC40A1 gene in colorectal cancer condition | [7] | ||||
TF Protein Name |
Transcription factor 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor 4 (TCF4) has been reported to activate the transcription of SLC40A1 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter Iron-regulated transporter 1. | |||||
Transcriptional Phenomenon2 |
Binding to SLC40A1 gene in glioblastoma multiforme condition | [8] | ||||
TF Protein Name |
Transcription factor 4 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Temozolomide | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor 4 (TCF4) has been reported to bind to the transcription of SLC40A1 gene in glioblastoma multiforme condition, which leads to an affected expression of the drug transporter Iron-regulated transporter 1. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
AR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC40A1 gene in prostate cancer condition | [9] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to activate the transcription of SLC40A1 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Iron-regulated transporter 1. | |||||
HNF4A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC40A1 gene in health condition | [10] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC40A1 gene in health condition, which leads to an affected expression of the drug transporter Iron-regulated transporter 1. | |||||
PPARD |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC40A1 gene in myofibroblast condition | [11] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor delta | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Peroxisome proliferator-activated receptor delta (PPARD) has been reported to repress the transcription of SLC40A1 gene in myofibroblast condition, which leads to a decreased expression of the drug transporter Iron-regulated transporter 1. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC40A1 gene in hematopoiesis condition | [12] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Erythroid transcription factor (GATA1) has been reported to bind to the transcription of SLC40A1 gene in hematopoiesis condition, which leads to an affected expression of the drug transporter Iron-regulated transporter 1. | |||||
Transcriptional Phenomenon2 |
Binding to SLC40A1 gene in megakaryocytes condition | [13] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Erythroid transcription factor (GATA1) has been reported to bind to the transcription of SLC40A1 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Iron-regulated transporter 1. | |||||
Transcriptional Phenomenon3 |
Direct binding to SLC40A1 gene | [3] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Liver; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC40A1 gene, which in turn affects the expression or function of the drug transporter Iron-regulated transporter 1. | |||||
GATA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC40A1 gene in hematopoiesis condition | [12] | ||||
TF Protein Name |
Endothelial transcription factor GATA-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Endothelial transcription factor GATA-2 (GATA2) has been reported to activate the transcription of SLC40A1 gene in hematopoiesis condition, which leads to an increased expression of the drug transporter Iron-regulated transporter 1. | |||||
GATA4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC40A1 gene in gastric cancer condition | [14] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Metformin | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) has been reported to activate the transcription of SLC40A1 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Iron-regulated transporter 1. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC40A1 gene | [4] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC40A1 gene, which in turn affects the expression or function of the drug transporter Iron-regulated transporter 1. | |||||
PRDM14 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC40A1 gene | [15] | ||||
TF Protein Name |
PR domain zinc finger protein 14 | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
PR domain zinc finger protein 14 (PRDM14) can directly bind to the SLC40A1 gene, which in turn affects the expression or function of the drug transporter Iron-regulated transporter 1. | |||||
ZNF217 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC40A1 gene in breast cancer condition | [16] | ||||
TF Protein Name |
Zinc finger protein 217 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Zinc finger protein 217 (ZNF217) has been reported to bind to the transcription of SLC40A1 gene in breast cancer condition, which leads to an affected expression of the drug transporter Iron-regulated transporter 1. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NANOG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC40A1 gene in health condition | [17] | ||||
TF Protein Name |
Homeobox protein NANOG | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Homeobox protein NANOG (NANOG) has been reported to bind to the transcription of SLC40A1 gene in health condition, which leads to an affected expression of the drug transporter Iron-regulated transporter 1. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC40A1 gene | [15] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Embryo; Liver; Lung; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC40A1 gene, which in turn affects the expression or function of the drug transporter Iron-regulated transporter 1. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC40A1 gene | [2] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC40A1 gene, which in turn affects the expression or function of the drug transporter Iron-regulated transporter 1. | |||||
FOXM1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC40A1 gene in breast cancer condition | [18] | ||||
TF Protein Name |
Forkhead box protein M1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Forkhead box protein M1 (FOXM1) has been reported to activate the transcription of SLC40A1 gene in breast cancer condition, which leads to an increased expression of the drug transporter Iron-regulated transporter 1. | |||||
FOXP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC40A1 gene | [15] | ||||
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
Tissue |
Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein P1 (FOXP1) can directly bind to the SLC40A1 gene, which in turn affects the expression or function of the drug transporter Iron-regulated transporter 1. | |||||
Class3.4: Heat shock factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
HSF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC40A1 gene in ferroptosis condition | [19] | ||||
TF Protein Name |
Heat shock factor protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
Ferroptosis [ICD11: N.A.] | |||||
Tissue |
Heart | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Hsf1 mice | |||||
Detailed Description |
Heat shock factor protein 1 (HSF1) has been reported to repress the transcription of SLC40A1 gene in ferroptosis condition, which leads to a decreased expression of the drug transporter Iron-regulated transporter 1. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
ELK3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to MIR155HG gene in hypoxia condition | [20] | ||||
TF Protein Name |
ETS domain-containing protein Elk-3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
ETS domain-containing protein Elk-3 (ELK3) has been reported to bind to the transcription start site of the MIR155HG gene in hypoxia condition, which leads to an affected expression of the drug transporter Iron-regulated transporter 1. | |||||
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC40A1 gene | [4] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC40A1 gene, which in turn affects the expression or function of the drug transporter Iron-regulated transporter 1. | |||||
MYB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC40A1 gene | [3] | ||||
TF Protein Name |
Transcriptional activator Myb | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional activator Myb (MYB) can directly bind to the SLC40A1 gene, which in turn affects the expression or function of the drug transporter Iron-regulated transporter 1. | |||||
Class4.1: High-mobility group domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SOX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC40A1 gene in colorectal cancer condition | [21] | ||||
TF Protein Name |
Transcription factor SOX-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor SOX-2 (SOX2) has been reported to activate the transcription of SLC40A1 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter Iron-regulated transporter 1. | |||||
Class6.3: p53 domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
TP53 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC40A1 gene in atherosclerosis condition | [22] | ||||
TF Protein Name |
Cellular tumor antigen p53 | Transcription Factor Info | ||||
Studied Phenotype |
Atherosclerosis [ICD11: BD40] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Cellular tumor antigen p53 (TP53) has been reported to activate the transcription of SLC40A1 gene in atherosclerosis condition, which leads to an increased expression of the drug transporter Iron-regulated transporter 1. | |||||
TP63 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC40A1 gene in epithelial to mesenchymal transition condition | [23] | ||||
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC40A1 gene in epithelial to mesenchymal transition condition, which leads to an affected expression of the drug transporter Iron-regulated transporter 1. | |||||
Class6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GRHL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC40A1 gene | [2] | ||||
TF Protein Name |
Grainyhead-like protein 2 homolog | Transcription Factor Info | ||||
Tissue |
Breast; Bronchus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC40A1 gene, which in turn affects the expression or function of the drug transporter Iron-regulated transporter 1. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SMAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC40A1 gene in epithelial ovarian cancer condition | [24] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to bind to the transcription of SLC40A1 gene in epithelial ovarian cancer condition, which leads to an affected expression of the drug transporter Iron-regulated transporter 1. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.